Seres Therapeutics, Inc.
MCRB
Revenue
0.00
0.000.00%
3 Months ChangeAssets
321.73M
▼-19.53M▼-5.72%
3 Months ChangeLiabilities
408.81M
▲7.81M▲1.95%
3 Months ChangeFree Cash Flow
-35.30M
▲45.35M▲56.23%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-01
Form 8-K
ID: 0001193125-24-230144
2024-09-26
Form 8-K
ID: 0001193125-24-226929
2024-09-12
Form 8-K
ID: 0001193125-24-217627
2024-08-15
Form 8-K
ID: 0001140361-24-037388
2024-08-13
Form 10-Q
ID: 0000950170-24-095821
2024-08-13
Form 8-K
ID: 0001193125-24-199382
2024-08-06
Form 8-K
ID: 0001140361-24-035951
2024-08-06
Form 8-K
ID: 0001140361-24-035799
2024-05-08
Form 10-Q
ID: 0000950170-24-055159
2024-05-08
Form 8-K
ID: 0001193125-24-133766